Loading...
Nitazoxanide: A first-in-class broad-spectrum antiviral agent
Originally developed and commercialized as an antiprotozoal agent, nitazoxanide was later identified as a first-in-class broad-spectrum antiviral drug and has been repurposed for the treatment of influenza. A Phase 2b/3 clinical trial recently published in The Lancet Infectious Diseases found that o...
Na minha lista:
| Udgivet i: | Antiviral Res |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The Author. Published by Elsevier B.V.
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7113776/ https://ncbi.nlm.nih.gov/pubmed/25108173 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2014.07.014 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|